These are two companies that behind the groundbreaking weight loss drugs that have helped millions of Americans struggling with obesity live better, longer lives, everything else. These are the two companies that really broke ground. Until now, neither of these two popular drugs have been covered by Medicare for weight loss and they've only rarely been covered by Medicaid. They've often cost consumers more than $1,000 per month and some a lot more than that. Americans have been spending as much as 520% more for Zepbound and 1,400% more for WeGovy than patients in Europe. (04:10–04:20)
CLAIM
Asserts that certain weight loss drugs were not covered by Medicare and rarely by Medicaid.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
